BNT logo

BNT

Brookfield Wealth Solutions Ltd. Class A Exchangeable Limited

$44.62
+$1.03(+2.36%)
55
Overall
90
Value
20
Tech
--
Quality
Market Cap
$13.34B
Volume
54.33K
52W Range
$29.13 - $49.44
Target Price
$36.00

Latest News for BNT

Brenntag AG (0MPT) Gets a Sell from DZ BANK AG
TipRanks Auto-Generated Intelligence Newsdesk9 days agoNov 15, 2025

DZ BANK AG analyst Peter Spengler maintained a Sell rating on Brenntag AG yesterday. The company’s shares closed last Thursday at €49.17. According......

Kepler Capital Reaffirms Their Hold Rating on Brenntag AG (0MPT)
TipRanks Auto-Generated Intelligence Newsdesk10 days agoNov 14, 2025

Kepler Capital analyst Martin Roediger maintained a Hold rating on Brenntag AG on November 12 and set a price target of €59.00. The company’s share......

3 Best Biotech Stocks to Buy Now, 11/12/2025, According to Top Analysts
Shalu Saraf12 days agoNov 12, 2025

Looking for top-rated biotech stocks to buy now? Recent analyst updates highlight three companies that have earned Strong Buy ratings from Top Wall......

Brenntag AG (0MPT) Receives a Hold from Barclays
TipRanks Auto-Generated Intelligence Newsdesk12 days agoNov 12, 2025

Barclays analyst Gaurav Jain maintained a Hold rating on Brenntag AG today and set a price target of €46.00. Jain covers the Consumer Defensive sec......

Jefferies Sticks to Their Buy Rating for BioNTech SE (BNTX)
TipRanks Auto-Generated Intelligence Newsdesk12 days agoNov 12, 2025

In a report released today, Akash Tewari from Jefferies maintained a Buy rating on BioNTech SE, with a price target of $151.00. Tewari covers the H......

BioNTech’s Earnings Call: Progress Amid Challenges
TipRanks Auto-Generated Newsdesk19 days agoNov 05, 2025

Biontech Se Sponsored Adr (($BNTX)) has held its Q3 earnings call. Read on for the main highlights of the call. BioNTech’s recent earnings call pai......

Analysts Offer Insights on Healthcare Companies: Hims & Hers Health (HIMS), BioNTech SE (BNTX) and Precision BioSciences (DTIL)
Howard Kim20 days agoNov 04, 2025

Analysts have been eager to weigh in on the Healthcare sector with new ratings on Hims & Hers Health (HIMS – Research Report), BioNTech SE (BNTX – ......

BioNTech’s Latest Study on BNT327: A Potential Game-Changer in Lung Cancer Treatment
TipRanks Clinical-Trials-Auto-Generated Newsdeska month agoOct 27, 2025

Biontech Se Sponsored Adr (($BNTX)) announced an update on their ongoing clinical study. BioNTech SE is currently sponsoring a Phase II clinical st......

Genmab and BioNTech’s Promising Study on Metastatic Colorectal Cancer Treatment
TipRanks Clinical-Trials-Auto-Generated Newsdeska month agoOct 27, 2025

Genmab (Otc) (($GMAB)), Biontech Se Sponsored Adr (($BNTX)) announced an update on their ongoing clinical study. Genmab and BioNTech SE are collabo......

Pfizer and BioNTech’s New Shingles Vaccine Study: A Potential Game Changer
TipRanks Clinical-Trials-Auto-Generated Newsdeska month agoOct 27, 2025

Pfizer Inc (($PFE)), Biontech Se Sponsored Adr (($BNTX)) announced an update on their ongoing clinical study. Pfizer Inc. and BioNTech SE are condu......

News data is sourced from MarketXLS API and updated regularly.
Showing 10 of 14 articles.

ABCD
1SymbolPriceChangeVol
2BNT$44.62+2.4%54.33K
3
4
5
6

Get Brookfield Wealth Solutions Ltd. Class A Exchangeable Limited Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.